1. Home
  2. MYPS vs STRO Comparison

MYPS vs STRO Comparison

Compare MYPS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

N/A

Current Price

$0.47

Market Cap

60.3M

Sector

Technology

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$16.42

Market Cap

332.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYPS
STRO
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
332.8M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MYPS
STRO
Price
$0.47
$16.42
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $47.23
AVG Volume (30 Days)
★ 293.0K
284.8K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $235,097,000.00
$38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.40
$0.72
52 Week High
$0.99
$43.85

Technical Indicators

Market Signals
Indicator
MYPS
STRO
Relative Strength Index (RSI) 44.15 31.62
Support Level $0.42 $14.81
Resistance Level $0.50 $17.33
Average True Range (ATR) 0.03 0.92
MACD 0.00 0.21
Stochastic Oscillator 56.18 44.34

Price Performance

Historical Comparison
MYPS
STRO

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: